Over 500 companies, including Bharat Petroleum (BPCL) and IRCTC, are set to announce their quarterly earnings on August 13, ...

Union Minister Dr. Jitendra Singh launched new animal biotechnologies and India's first animal stem cell biobank in Hyderabad ...

India’s pharma sector is at a turning point transitioning from a global generics powerhouse to a serious contender in biotech ...

India's nutraceutical industry is stepping confidently onto the global stage--and Bharat Nutraverse Expo 2025 is set to lead ...

Krystal Biotech (KRYS) announced that on July 24, 2025, Japan’s Ministry of Health, Labour and Welfare, MHLW, granted marketing authorization to VYJUVEK for the treatment of wounds in patients ...

Food and Drug Administration commissioner Marty Makary has chosen former biotech executive George Tidmarsh as the agency’s top drug regulator, the agency confirmed Monday.

The U.S. Food and Drug Administration named ex-biotech exec George Tidmarsh as its chief drug regulator. FDA Commissioner Marty Makary called Tidmarsh an "accomplished physician-scientist and leader." ...

Every so often, activist investors swarm around underperforming companies in a certain industry and pressure them to change strategy. Right now, it’s biotech startups that are flush with cash ...

Top experts from Amgen, CBIZ & Intrepid discuss 2025 trends in healthcare, biotech, and life sciences. Explore key insights on AI, VC funding, and valuations.

Stanford's George Tidmarsh has authored 143 scientific papers and patents, as well as played a central role in developing seven FDA-approved drugs.

Michelle Xia gained experience at U.S. pharmaceutical firms before launching her own biotech company back home in China. In a trial last year, the firm’s cancer drug outperformed the world’s ...

That's why, in my opinion, now is a great time to load up on this biotech giant while it's down -- and then sit back and wait for the new era of growth to start powering the stock higher.